See All Authors »

James Brumley


InvestorPlace.com

James Brumley is a former stock broker, registered investment adviser and Director of Research for an options-focused newsletter. He's now primarily a freelance writer, tapping more than a decade's worth of broad experience to help investors get more out of the market. With a background in technical as well as fundamental analysis, James touts stock-picking strategies that combine the importance of company performance with the power of stock-trade timing. He believes this dual approach is the only way an investor has a shot at consistently beating the market. James' work has appeared at several websites including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multi-pronged approach to investing.

Latest Features

SLIDE SHOW
November 2017

32 Companies That Amazon Could Ruin

Amazon.com (AMZN) has brought pain and misery to numerous companies since its founding in 1994. This well-documented phenomenon really picked up the pace over the past decade, however, with many organizations ...

See More From: Stocks & Bonds

SLIDE SHOW
October 2017

7 Retail Stocks That Need to Be Rescued

Nordstrom (JWN) has a respected name in retailing, but it can be tough to start a much-needed turnaround when impatient shareholders meddle in such an effort. However, for a brief moment, it looked like ...

See More From: Stocks & Bonds

SLIDE SHOW
October 2017

7 Dow Jones Stocks That Pack a Growthy Punch

In the shadow of the Dow Jones Industrial Average’s 27% runup over the past year, investors are understandably hesitant to plow into stocks as they tiptoe to new record highs. We've simply gone a little ...

See More From: Stocks & Bonds

SLIDE SHOW
February 2017

9 Top Pharmaceutical Stocks to Buy for the Dividends

When investors are on the hunt for income-driving dividend stocks, they often gravitate toward utilities or consumer staples names. And well they should. Those businesses are essentially recession- proof, ...

See More From: Stocks & Bonds

SLIDE SHOW
October 2016

10 Hot Stocks That Made Millionaires in 10 Years

Do you own any hot stocks that have dished out a 1,000% return in a decade or less? Those are the kind of results you only hear about when they happen to someone else … and all too often, those tales ...

See More From: Stocks & Bonds

SLIDE SHOW
November 2016

9 Biotech Stocks to Put on Your Radar

While the foreseeable future for the broad market may not be clear, there’s one group that still moves independently of stocks as a whole — biotech stocks. These stocks are still pushed and pulled ...

See More From: Stocks & Bonds

Stocks & Bonds
September 2016

10 Stocks You Should Dump Right Now

The bears tipped their hand last Friday, and more is coming. Now might be the time to reduce your market exposure.

See More From: Stocks & Bonds

Tech Stocks
September 2016

4 Companies That Could and Should Buy Twitter

These firms have the best shot at turning Twitter to profitability.

See More From: Tech Stocks

Stocks & Bonds
August 2016

7 Stocks to Buy for a Possible Fed Rate Hike

Did strong job growth accelerate Janet Yellen's rate hike timeline?

See More From: Stocks & Bonds